Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 340 participants.

Also called NCT07819175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 340 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07819175
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07819175. Randomized; no masking; primary purpose treatment. Start 2026-10-08 (anticipated); primary completion 2028-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Pulsed Field Ablation - pulmonary vein isolation
Intervention (Device)
Pulsed Field Ablation - Pulmonary Vein Isolation + Superior Vena Cava Isolation
Lead sponsor
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct07819175
Content hash
f0fe777fe032f5a639fcfa43cc465848948329bead3fa127e1f074a92a720702